Brief: Neurotrope Says Unit Executed Services Agreement With Worldwide Clinical Trials
July 29 (Reuters) - Neurotrope Inc NTRP.O :
* NEUROTROPE- ON JULY 23, UNIT, EXECUTED A SERVICES
AGREEMENT WITH
WORLDWIDE CLINICAL TRIALS, INC
* NEUROTROPE- AGREEMENT RELATES TO SERVICES FOR UNIT'S PHASE
2
CLINICAL STUDY ASSESSING BRYOSTATIN IN TREATMENT OF MODERATELY
SEVERE ALZHEIMER’S DISEASE
* NEUROTROPE- UNIT'S TOTAL ESTIMATED BUDGET FOR THE
SERVICES,
INCLUDING PASS-THROUGH COSTS, IS APPROXIMATELY $9.8 MILLION
Source text: (https://bit.ly/30fsVqp)
Further company coverage: NTRP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NextTrip
See all newsBrief: Nexttrip - Announces Joint Venture With Ttand In Canada - SEC Filing
Nexttrip Inc reports results for the quarter ended August 31 - Earnings Summary
Nexttrip Inc expected to post a loss of 14 cents a share - Earnings Preview
Nexttrip Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: NextTrip Enters At-The-Market Offering Agreement With Titan Partners Securities On August 31